Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

BACKGROUND: 5-Fluorouracil (5FU), Folinic acid (FA), and Oxaliplatin (FOLFOX) or 5FU, FA, and Irinotecan (FOLFIRI) are standard regimens for palliative chemotherapy of metastatic colon cancer. Since data showing the influence of dose reduction in palliative treatment are rare, the objective of this...

詳細記述

保存先:
書誌詳細
出版年:BMC Cancer
主要な著者: Munker, Stefan, Gerken, Michael, Fest, Petra, Ott, Claudia, Schnoy, Elisabeth, Fichtner-Feigl, Stefan, Wiggermann, Philipp, Vogelhuber, Martin, Herr, Wolfgang, Stroszczynski, Christian, Schlitt, Hans Jürgen, Evert, Matthias, Reng, Michael, Klinkhammer-Schalke, Monika, Teufel, Andreas
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913883/
https://ncbi.nlm.nih.gov/pubmed/29685155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4380-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料